SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Cashflow Statement
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Cash Flow from Financing Activities | ₹199 Cr | ₹42 Cr | ₹617 Cr |
What is the latest Cash Flow from Financing Activities ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹199 Cr |
| Mar2024 | ₹42 Cr |
| Mar2023 | ₹617 Cr |
How is Cash Flow from Financing Activities of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹199 Cr | 369.89 | |
| Mar2024 | ₹42 Cr | -93.12 | |
| Mar2023 | ₹617 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹7,617.6 Cr | 28% | 68.5% | 40.5% | Stock Analytics | |
| SAGILITY | ₹19,516.5 Cr | -1% | 0.7% | -5.4% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹18,776.7 Cr | -0.3% | 10.4% | -27.6% | Stock Analytics | |
| PRIME FOCUS | ₹18,557.8 Cr | -6.3% | -22.2% | 155.3% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹16,478.2 Cr | 8.3% | 9.5% | -1.2% | Stock Analytics | |
| INDEGENE | ₹12,463.0 Cr | 0.6% | 5.4% | -14% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | 28% |
68.5% |
40.5% |
| SENSEX | 1.1% |
-2.1% |
-6.4% |
You may also like the below Video Courses